Navigation Links
Registration Now Open for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
Date:3/5/2013

SAN DIEGO, March 5, 2013 /PRNewswire/ -- The Association of Bioscience Financial Officers (ABFO) today announced the opening of registration for the 2013 National Conference, which will be held May 28-31 at the Hilton San Diego Bayfront.

Approximately 200 financial executives from life sciences companies are expected to attend the conference to network and discuss how they can create and capture value for their respective organizations. The conference includes keynote speakers and breakout panels all with a focus on value beyond just the areas of finance and accounting, encompassing operational excellence, business development, regulatory expertise and team building.  

"Financial executives play a critical role in the operations of their organizations," said Brandi Roberts , Chief Financial Officer of ADVENTRX Pharmaceuticals, Inc. and the 2013 National Conference Chair. "At this year's national conference, we want to take a closer look at how we can add value to our organizations. We have a stellar lineup of thought leaders from the bioscience industry to prepare us for new challenges and opportunities ahead."

ABFO will welcome numerous keynote speakers, including:

  • Michael Abrashoff, former Navy Commander and author, who will talk about his leadership strategies as documented in his book "It's Your Ship"
  • Dan Bradbury , former President and CEO, and Mark Foletta , former CFO, of Amylin Pharmaceuticals who will discuss exit strategies by giving a first-hand account of "The Amylin Story"
  • Joe Quinlan , Managing Director and Chief Market Strategist of U.S. Trust – Bank of America who is a repeat presenter at the ABFO national conference and will present a lively overview on the state of the US economy
  • Karin Eastham , director for 4 public biotechnology companies, will discuss what directors expect from CFOs today – and it's not just about the numbers!

In addition to the keynote presentations, attendees of the conference will also be able to participate in break-out sessions led by industry executives with first-hand expertise in each area, including:

  • Effective Management of Clinical Trials and CROs
  • Current D&O Landscape and Say on Pay
  • Update on IPOs
  • Lean in Biosciences
  • M&A Considerations
  • Treasury-Navigating Change
  • Role of Orphan Drugs in Biotech/Pharma
  • Accounting and SEC Update

Registration can be completed online at www.abfointernational.org/conference through May 15, 2013.  The cost to attend the conference is only $1,200 and 15 hours of continuing education credits are available.  For more information about the conference, contact Brandi Roberts at broberts@adventrx.com.

Sponsors of the event include AON, Bank of America Merrill Lynch, Brinson Patrick , Ernst & Young, Oxford Finance and Cooley LLP.  The conference is also supported by Russo Partners, PR Newswire and BioCentury.

About the Association of Bioscience Financial Officers

Formed in 1989, the Association of Bioscience Financial Officers has eleven chapters that serve as forums for the exchange of information about the industry and networking. Regional chapters are based in top bioscience concentrations to allow for face-to-face meetings and discussion of hot topics of interest to bioscience financial officers. The regional chapters meet annually for the ABFO National Conference for extended networking. For more information, visit www.abfointernational.org.


'/>"/>
SOURCE Association of Bioscience Financial Officers (ABFO)
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Registration now open: 2012 Regional, State, and Local Initiatives in Nanotechnology
2. Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration
3. National Defense Industrial Association (NDIA) Opens Registration For 2012 Biosurveillance Conference, Set For August 27-28 in Washington, D.C.
4. Regulus Files Registration Statement for Proposed Initial Public Offering
5. Bayer CropScience Announces Registration for use of Alion on Grapes in California
6. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
7. Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
8. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
9. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
10. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
11. Inovios Scientific Advisory Board Chairman Elected as a Fellow by the American Association for the Advancement of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017  UBM and the Massachusetts ... their extended partnership and the third annual Massachusetts Medtech ... the 21 st Annual MassMEDIC Conference held ... May 3-4, 2017. MassMEDIC will ... (ADVAMED) President and CEO, Scott Whitaker , ...
(Date:3/22/2017)... , March 22, 2017   iSpecimen ®, ... announced that Doctors Pathology Service (DPS), a ... of the United States , has ... Delaware Health Information Network (DHIN) to make human ... The novel program, announced in 2015 as ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT ... (the "Company" or "Propellon"), a start-up created by ... anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive capital, ... program. The seed funding enables Propellon to accelerate ... the Company for financing and/or entering a strategic ...
(Date:3/22/2017)... , ... March 21, 2017 , ... Premier executive recruitment ... Life Science Search Firm by Hunt Scanlon Media. , Hunt Scanlon Media ... the most widely referenced global news source in the human capital sector. , “It ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
Breaking Biology News(10 mins):